Alastair needs to read this post23 Nov 2020 12:00
good post. I disagree with some points, but hej its a BB, good to see others thoughts.
My own feeling is that tech transfer is still not complete, no where near it. I liked the video showing what the kits would be, but if I wanted to avoid saying too much bad news, I would state that testing of "batch prototypes" was the testing going on now, and when tech transfer was complete a much bigger clinical trial would be done. Testing of batches to see if swabs work would be done on prototypes anyway. TT some way off.
Alternative is TT is complete as far as it can, and swabs need to be tested by company first to see if they work. If the do, press the button on production. Then why not say TT is all but complete but we wont spend money on production till we know it works.
If tech transfer was complete, why not say " TT will be complete in Q4".
Im not annoyed at the delay. This is a high risk undertaking with new technology, with a company with little in the way of bring production to market. Risk is large, so is upside, if I wanted safe I would put money in Disney.
More concerned with the obfuscation of details. Bad news may or might not be included in this RNS. The idea of an RNS is to ensure we are all on the same page. 100's of people across a number of companies and government know the status and a good idea of timelines, those people have a trading advantage. RNS is meant to ensure share holder and potential share holder have the same set of facts. This RNS failed in a major way to address that, and was a poor attempt to shore up SP. The share price is not failing big time cos timelines may have changed or we have a new method, it's failing because trust about being informed is has disappeared. Having to second guess what an RNS means, means it wasn't as RNS.
Im gonna hold, I think risk/reward profile on the cancer drugs alone warrant the investment, but I won't be having a cheeky top up, even at these prices. CEO duty is primarily to share holders, and that means all share holders.
Just tell us estimated TT time line, paint is with "may change" statements etc etc. The alternative is company has no idea when it will be complete, and that ain't a good thing.
Sign In
Follow the stocks
